What is a share repurchase program?
A share repurchase program is a resolution by a company's board of directors authorizing management to spend a specified dollar amount (or a specified share count) buying back the company's own stock over a specified time window. The authorization is capacity, not a commitment. Management can execute all of it, some of it, or none of it, depending on cash flow, share price, and competing capital priorities.
Three numbers to always check when a program is announced: the dollar cap, the time window, and any prior unused capacity being carried forward. A "$100M new authorization" is very different if the prior authorization had $80M unused.
The four ways a program gets executed
- Open-market repurchase (10b-18) — the most common. Company buys shares on the open market subject to Rule 10b-18's safe-harbor conditions (25% of ADV daily volume cap, no trading in the first or last 10-30 minutes of the session, etc.). Slow drip, months to years to complete.
- Rule 10b5-1 plan — an automated repurchase schedule set in advance so the company can trade even during closed insider windows. Filed with the SEC and pre-committed.
- Accelerated Share Repurchase (ASR) — a contract with an investment bank. Cash paid up front, bank delivers a large block of shares immediately, final settlement price averaged over a lookback period. Firm commitment.
- Tender offer — public offer to buy a specified number of shares at a specified price (fixed or Dutch auction). Disclosed via Schedule TO. Rare, high-signal.
Why do authorizations often go unexecuted?
Board authorizations expire unused for a variety of reasons — most commonly because share prices ran higher than the range management was targeting, because free cash flow came in lower than expected, or because the company found a better use for capital (an acquisition, a debt paydown, a dividend increase). Across the small-cap universe, roughly 60-70% of authorized program capacity is typically deployed over the stated window. That means 30-40% of "repurchase announcements" are essentially free options that expire worthless from the shareholder's perspective.
How do companies disclose activity?
Every quarter, US-listed issuers report actual repurchase activity in Item 703 of the 10-Q (or Item 5(c) of the 10-K). The table shows:
- Total shares repurchased in each month of the quarter
- Weighted average price paid per share
- Number of shares purchased under publicly announced programs
- Approximate dollar value of shares that may yet be purchased under the program
The last column — remaining capacity — is the single most-useful data point for tracking whether a program is being deployed or is sitting idle.
Track new small-cap authorizations in real time
Free daily EDGAR alert. Under $300M market cap only.
Send me the filings →How do you evaluate a specific program?
Size as % of float
Dollar amounts alone are meaningless. A $50M program is trivial for a $10B company and enormous for a $200M company. Divide the authorization by the current market cap to get a "gross size" percentage; divide by the float value (float shares × price) for the more accurate figure.
Time window
A program authorized "through December 31, 2027" from a 2026 board meeting is roughly one-third the intensity of one authorized "through December 31, 2026." Longer windows mean lower daily and weekly execution pressure.
Funding source
The strongest programs are funded from operating cash flow. Programs funded by drawing on credit facilities at rates significantly above the equity's earnings yield destroy value even if the repurchase pop is positive in the short term. Look for language in the 8-K or press release like:
- Strongest: "funded from cash on hand" or "from operating cash flow"
- Medium: "funded from a combination of cash and credit facility"
- Weakest: "financed through new senior notes" or "financed through an increase in the credit facility"
Simultaneous issuance
If the company is simultaneously running an at-the-market (ATM) shelf offering, issuing convertible notes with call spreads, or executing large stock-based compensation grants, the repurchase may just be neutralizing dilution rather than reducing share count. The net change in diluted shares outstanding tells the true story.
Programs that historically outperformed
Empirically, the small-cap share repurchase programs that produced the strongest post-announcement returns share a cluster of features:
- Authorization >5% of float
- Time window of 12-24 months (fast execution)
- Funded from operating cash flow, not debt
- Announced within 30 days of a >20% share price drawdown (opportunistic timing)
- Simultaneous with insider open-market buying (aligned incentives)
Every one of these signals is disclosed in public filings. Our EDGAR pipeline surfaces them in our live repurchase tracker.
Common share repurchase misconceptions
"The company always finishes the program." False. Roughly 30-40% of authorized capacity typically expires unused.
"A refreshed authorization means more repurchases." Not necessarily. If the prior program had significant unused capacity that is being replaced (not stacked), the practical increase in capacity may be small or zero.
"The 1% repurchase tax stopped repurchases." No. Aggregate US repurchase dollars continued growing in 2023 and 2024. The 1% excise is not decisive at current rates. Higher proposed rates (4-7%) would change corporate behavior more materially. See our repurchase tax analysis.
"All repurchases reduce share count." No. If a company is simultaneously issuing shares (executive compensation, convertibles, ATM offerings), the repurchase may simply offset dilution. Track net share count changes, not gross repurchase spending.
Frequently asked questions
How long does a typical share repurchase program last?
12-36 months is the most common window. Shorter windows (6-12 months) signal management's confidence that the price is currently attractive; longer windows (36+ months) provide flexibility but dilute the near-term intensity of each dollar authorized.
Does a share repurchase program guarantee price support?
No. The authorization is capacity, not commitment. Whether actual price support materializes depends on execution — how much of the authorization gets deployed, at what pace, and whether the 25%-of-ADV cap under Rule 10b-18 produces a meaningful demand impulse in the specific stock.
Can a share repurchase program be canceled?
Yes. Boards can rescind or reduce authorizations at any time. Unused capacity does not have to be executed. In practice, cancellations are rare — more commonly a program simply expires with unused capacity that gets replaced by a new authorization.
Are share repurchase programs public information?
Yes. US public companies are required to disclose new share repurchase programs promptly (typically via 8-K Item 8.01) and to report quarterly execution details in Item 703 of the 10-Q or 10-K.
How is a share repurchase program different from a tender offer?
A tender offer is a public offer to buy a specified number of shares at a specified price by a specified date — a discrete event. A share repurchase program is an ongoing authorization to buy shares over months or years. Both are share repurchases; the mechanics differ significantly.
Do all authorized programs get executed?
No. Roughly 30-40% of authorized program capacity typically goes unused in the small-cap universe. Companies with a consistent track record of executing near 100% of their authorizations are meaningfully different from those that authorize aggressively but execute only a fraction.